WaveMan
WaveMan · Company
EVFM · Evofem Biosciences, Inc.
> Search tickers & screens ⌘K
LIVE
← All companies

EVFM Evofem Biosciences (EVFM) Insider Trading, Ownership & Congress Trades

Pharma & Biotech · Pharmaceutical preparations · CIK 0001618835
Quote by TradingView
Activist 13D
Insider buyers, 180 days
0
House members buying, 1 year
0
STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
0
13F, latest reported quarter

What the filings say about EVFM

Activist stakes (13D), 180 days
1 filing
Largest: 10.0% of the class

Evofem Biosciences insider trades (Form 4)

Form 4 buys and sells (codes P and S). Grants, option exercises and conversions excluded.

No insider purchases or sales are on record for Evofem Biosciences, Inc. in the period covered. Source: SEC Form 4 filings, as of 2026-10-28.

Insider
Filed
Shares
Value
Since filing
Zhang Yan
CFO
SELL
2024-01-12 SEC
104
$4
-81.4%
Context
  • First Form 4 purchase or sale (code P or S) here by this insider on our record.
  • 1 other insider sold within 30 days.
Insider activity: CFO Zhang Yan sold about $4 of EVFM on Jan 12, 2024; 1 other insider sold within 30 days.
Kamdar Kim P.
Director
SELL
2023-12-22 SECtraded 2023-12-21
10
$6
-90.2%
Context
  • First Form 4 purchase or sale (code P or S) here by this insider on our record.
  • 1 other insider sold within 30 days.
Insider activity: Director Kamdar Kim P. sold about $6 of EVFM on Dec 21, 2023, the largest insider sale at the company on our record; 1 other insider sold within 30 days.
PELLETIER SAUNDRA L
Chief Executive Officer
BUY
2022-05-31 SECtraded 2022-05-27
141,000
$49.4K
-100.0%
Context
  • 1 earlier Form 4 trade (code P or S) here by this insider (1 buy), the last on Dec 20, 2021.
  • The trade is 59.6% of the 236,722 shares held after it.
  • No other insider bought within 30 days.
Insider activity: Chief Executive Officer PELLETIER SAUNDRA L bought about $49.4K of EVFM on May 27, 2022.
Fitzpatrick Alexander A
General Counsel and Secretary
BUY
2021-12-20 SEC
25,000
$9.8K
-100.0%
Context
  • First Form 4 purchase or sale (code P or S) here by this insider on our record.
  • The trade is 7.4% of the 336,422 shares held after it.
  • 2 other insiders bought within 30 days.
Insider activity: General Counsel and Secretary Fitzpatrick Alexander A bought about $9.8K of EVFM on Dec 20, 2021, the largest insider purchase at the company on our record; 2 other insiders bought within 30 days.
File Justin J.
Chief Financial Officer
BUY
2021-12-20 SEC
40,594
$15.0K
-100.0%
Context
  • First Form 4 purchase or sale (code P or S) here by this insider on our record.
  • The trade is 8.4% of the 480,982 shares held after it.
  • 2 other insiders bought within 30 days.
Insider activity: Chief Financial Officer File Justin J. bought about $15.0K of EVFM on Dec 20, 2021, the largest insider purchase at the company on our record; 2 other insiders bought within 30 days.
6 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
See all insider buying · insider selling
Showing the latest few. to see 1 more transactions and use the screener and CSV export. We store only your email; there is no password.
Seven facts, ranked against the sector · Rank is not a forecast
Insiders
no insider buys or sells on file
Congress
no House purchase disclosed in the last 12 months
Funds
under five funds report holding it
Revenue
+4.2% year over year
more than 51% of Pharma & Biotech
Margin
1.9% net margin
more than 75% of Pharma & Biotech
Buybacks
no share repurchases reported
Short interest
<0.1% of the float short (float per yahoo 2026-10-26) · 1.0 days to cover · settled 2026-09-30
below 95% of Pharma & Biotech
The situation: each line is one rule over one dataset
HUB Cyber Security Ltd. disclosed a 5%+ stake (9.99%) in the last six months.
What changed in the last 30 days
Nothing new filed in the last 30 days

Watch EVFM

A free account keeps a watchlist and can send one email a day when insiders, funds or Congress file on the names in it. No password and no card.

The year, with the filings on it
Total return over 12 months. Each marker is a filing; hover or tap one for the detail.
-35.0%12M
-40%-17%+7%+30%2025-102025-122026-022026-042026-062026-082026-10 2026-08-04 · HUB Cyber Security Ltd. filed a 5%+ stake (9.99%)
13D/G stake
Indexed to 100, dividend-adjusted, not a price chart. When a name files heavily, the largest trades are drawn first.

Who owns EVFM: institutional holders (13F)

13F holdings, latest reported quarter
SEC 13F
No reported 13F holders

No fund above the reporting threshold listed this stock last quarter. That is a fact, not missing data.

Congress trades in EVFM

No Congress trades reported
No House member has disclosed a trade in this stock. See what Congress is buying.

Activist and 5% holders (13D/13G)

13D: intends to influence · 13G: passive
HUB Cyber Security Ltd.
Activist 13D · 2026-08-04
9.99%

EVFM planned insider sales (Form 144)

No planned-sale notices
No insider has filed to sell. Watch this after a run-up.
Executive pay vs shareholder return · Saundra Pelletier
CEO pay, headline and as actually paid, against the company's return and its chosen peers' (DEF 14A).
FY
CEO total
Actually paid
Other execs, avg
TSR
Peer TSR
2023
$1.5M
$1.5M
$309.2K
-99%
n/a
Tagged by the company under SEC Item 402(v). Returns are cumulative from the start of the disclosure period. Green where the company beat its own peer group.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
An activist crossed the 5% line with declared intent.
Each figure here is a federal filing, dated the day it went public, so you can test what was knowable then.
Backtest this pattern Open the screener
Same sector, ranked by filing activity
Sector by SEC SIC code
UTHRCPIXMRNAREGNLLYALNYMDGLCITRDNAVRTXNUVLTWST

EVFM financials

Revenue growth
+4.2%
XBRL, annual
Net margin
1.9%
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$18.0M
four quarters, 2025-07-01 to 2026-06-30
Net margin, TTM
-84.7%
net income over revenue, 2025-07-01 to 2026-06-30
Free cash flow, TTM
-$477.0K
operating cash flow minus capex, 2025-07-01 to 2026-06-30
Debt to equity
n/a
equity is zero or negative, the ratio has no meaning
Cash flow to debt
-1.30x
TTM operating cash flow over long-term 2021-12-31 (54 months older than the period end) plus current 2026-06-30
Return on equity
n/a
average equity is zero or negative
Return on assets
-139.5%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on invested capital
n/a
pre-tax loss, no effective tax rate to apply
Return on capital employed
n/a
capital employed is zero or negative
P/E, trailing
n/a
trailing loss, a multiple of a loss is not meaningful
Enterprise value
-$267.6K
market value at close 2026-10-27 on 2026-08-12 shares, plus long-term 2021-12-31 (54 months older than the period end) plus current 2026-06-30, minus cash 2026-03-31
FCF yield
-55.4%
TTM free cash flow over market value at close 2026-10-27
PEG, trailing
n/a
trailing loss, a multiple of a loss is not meaningful
Price as of 2026-10-27. Hover or tap a tile for its yearly and quarterly history.
Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
2025-122024-122023-122022-12
Revenue$20.2M$19.4M$18.2M$16.8M
Operating income$3.4M-$7.7M-$17.8M-$84.1M
Net income$391.0K-$8.9M$53.0M-$76.7M
EPS (diluted)0.00-0.110.05-167.42
Operating cash flow-$2.0M-$3.9M-$9.0M-$70.4M
Cash$578.0K$741.0Kn/a$2.8M
Buybacksn/an/an/a$18.0K
SEC XBRL, fiscal years, as known on 2026-10-28

EVFM Stock Sonar score 3/7 axes

Find similar shapesCompare

EVFM ranks highest on risk and compliance (72nd percentile) and growth (51st), and lowest on financial health (49th), among Pharma & Biotech peers.

Financial health
49
Inputs
  • Debt to equityequity is zero or negative, the ratio has no meaning
  • Cash flow to debt-1.30x · 49 pct, sector of 371
Growth
51
Inputs
  • Revenue growth, YoY+4.2% · 51 pct, sector of 505
  • Backlog growth, YoYno backlog line filed, or no year-earlier backlog
Risk and compliance
72
Inputs
  • Short interest, % of float+0.0% · 97 pct, sector of 813
  • Recalls per $1B revenue, 3yrevenue under $50M or not filed, so a count cannot be scaled to size
  • EPA cases per $1B revenue, 5yrevenue under $50M or not filed, so a count cannot be scaled to size
  • New text in Risk Factors, latest 10-K+11.3% · 46 pct, sector of 511
4 not measured: Profitability, Insider conviction, Institutional and government, US patents
  • Profitability needs 2 of 4 inputs, 1 present: average equity is zero or negative; capital employed is zero or negative; pre-tax loss, no effective tax rate to apply
  • Insider conviction needs 1 of 2 inputs, 0 present: no Form 4 purchase or sale (code P or S) in 180 days; no insider trades in 180 days
  • Institutional and government needs 1 of 4 inputs, 0 present: fewer than five funds report holding it; no Congress trades in 365 days; no federal contracts in 180 days; no lobbying filings in the last four quarters
  • US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet

3 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored

EVFM filings, in plain words

Read the full summary

1 activist Schedule 13D filing in the last 180 days declared an intent to influence the company, the largest for 10.0% of the class. Each figure is counted from SEC and House filings as of 2026-10-28, dated the day the filing was made public.

Explore insider trading and ownership data

Every company we track, ranked by each kind of filing
Insider buyingInsider sellingCongress stock tradesActivist 13D stakesForm 144 planned salesCEO pay vs performanceAll companies